Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-25,000
Closed -$2.17M 10576
2025
Q4
$2.17M Buy
+25,000
New +$2.01M ﹤0.01% 4907
2019
Q4
Sell
-50,000
Closed -$3.3M 8129
2019
Q3
$3.3M Buy
+50,000
New +$3.31M ﹤0.01% 2788
2018
Q2
Sell
-40,000
Closed -$3.84M 8005
2018
Q1
$3.84M Hold
40,000
﹤0.01% 2556
2017
Q4
$3.47M Buy
+40,000
New +$3.22M ﹤0.01% 2700
2015
Q4
Sell
-16,500
Closed -$678K 8360
2015
Q3
$678K Hold
16,500
﹤0.01% 3657
2015
Q2
$847K Buy
+16,500
New +$804K ﹤0.01% 3697
2015
Q1
Sell
-20,400
Closed -$956K 8873
2014
Q4
$956K Buy
+20,400
New +$958K ﹤0.01% 3604

Other funds holding CMA

UBS Group's CMA Position: Q1 2026 in Review

UBS Group sold out of Comerica (CMA) in Q1 2026, closing a stake of 1,343,812 shares — an estimated $117M sold.

UBS Group first reported a position in CMA in Q4 2014 and held it in 45 quarters. The position peaked at $117M in Q4 2025. 4 funds tracked by Wall St. Rank hold CMA as of Q1 2026.

  • UBS Group reported no remaining Comerica position as of Q1 2026 after selling out during the quarter.
  • UBS Group sold 1,343,812 Comerica shares in Q1 2026, an estimated $117M.
  • UBS Group first reported a position in Comerica in Q4 2014 and held it in 45 quarters.
  • UBS Group's Comerica position peaked at $117M in Q4 2025.
  • 4 funds tracked by Wall St. Rank held Comerica as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.